AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18387700 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 71
Study 18387700 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 71
Study 15713944 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg twice daily
Number of subjects: 2035
Study 15713944 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 400 mg twice daily
Number of subjects: 2035
Study 15713944 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2035
Study 12538431 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) 15,000 to 30,000 IU per week for 3 months
Number of subjects: 26
Study 12538431 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 26
Study 11761012 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole for 7 days
Number of subjects: 18
Study 11761012 — intervention group
Group type: COMPARATOR
Intervention: No omeprazole treatment
Number of subjects: 18
Study 9250109 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg beta-carotene/d for 4 years
Number of subjects: 54
Study 9250109 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 8214666 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg MCA
Number of subjects: 96
Study 8214666 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg MCA
Number of subjects: 96
Study 8214666 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg/kg MCA
Number of subjects: 96
Study 8214666 — intervention group
Group type: EXPERIMENTAL
Intervention: DPD (0.01 and 0.02 mg/kg)
Number of subjects: 96
Study 8214666 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 96
Study 3423731 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 14
Study 3423731 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 31540384 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine (RW)
Number of subjects: 20
Study 31540384 — intervention group
Group type: EXPERIMENTAL
Intervention: Indian pale ale beer (IPA)
Number of subjects: 20
Study 31540384 — intervention group
Group type: EXPERIMENTAL
Intervention: Blonde beer
Number of subjects: 20
Study 31540384 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-alcoholic beer (free)
Number of subjects: 20
Study 31540384 — intervention group
Group type: EXPERIMENTAL
Intervention: All beers
Number of subjects: 20
Study 31540384 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygenic activity score (PAS)
Number of subjects: 20
Study 28974071 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep-deprived group (SLD, n=10)
Number of subjects: 20
Study 28974071 — intervention group
Group type: COMPARATOR
Intervention: Rested group (R, n=10)
Number of subjects: 20
Study 25510857 — intervention group
Group type: EXPERIMENTAL
Intervention: L-dopa (50 mg levodopa and 12.5 mg carbidopa)
Number of subjects: 100
Study 25510857 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 23663556 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care intervention for depression
Number of subjects: 36
Study 23663556 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 36
Study 20409050 — intervention group
Group type: EXPERIMENTAL
Intervention: Musical distraction with headphones
Number of subjects: 118
Study 20409050 — intervention group
Group type: EXPERIMENTAL
Intervention: Musical distraction without headphones
Number of subjects: 118
Study 20409050 — intervention group
Group type: COMPARATOR
Intervention: Standard care control
Number of subjects: 118
Study 19006463 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based therapy (IBT)
Number of subjects: 62
Study 19006463 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (WL)
Number of subjects: 62
Study 17585666 — intervention group
Group type: EXPERIMENTAL
Intervention: Red-hot needle therapy combined with blood-letting puncture and cupping
Number of subjects: 96
Study 17585666 — intervention group
Group type: COMPARATOR
Intervention: Halometasone cream (control)
Number of subjects: 96
Study 15082482 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pulse cyclophosphamide plus methylprednisolone
Number of subjects: 32
Study 15082482 — intervention group
Group type: COMPARATOR
Intervention: Continuous cyclophosphamide plus azathioprine
Number of subjects: 32
Study 15082482 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32
Study 11152840 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative risk reduction
Number of subjects: 400
Study 11152840 — intervention group
Group type: COMPARATOR
Intervention: Absolute risk reduction
Number of subjects: 400
Study 11152840 — intervention group
Group type: COMPARATOR
Intervention: Number of patients needed to be treated to prevent 1 death
Number of subjects: 400
Study 11152840 — intervention group
Group type: COMPARATOR
Intervention: Increased life expectancy (distractor)
Number of subjects: 400
Study 11152840 — intervention group
Group type: COMPARATOR
Intervention: Decreased hospitalization rate (distractor)
Number of subjects: 400
Study 11152840 — intervention group
Group type: COMPARATOR
Intervention: Decreased cost (distractor)
Number of subjects: 400
Study 9479674 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR)
Number of subjects: 60
Study 9479674 — intervention group
Group type: COMPARATOR
Intervention: Active Listening (AL)
Number of subjects: 60
Study 7809761 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemonucleolysis
Number of subjects: 0
Study 7809761 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous nucleotomy
Number of subjects: 0
Study 7809761 — intervention group
Group type: COMPARATOR
Intervention: Conservative therapy (bed rest, information, analgesics)
Number of subjects: 0
Study 3056084 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (100 mg continuous infusion in 5% glucose over 10 h)
Number of subjects: 20
Study 3056084 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5% glucose)
Number of subjects: 20
Study 31246283 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg every 2 weeks until further progression)
Number of subjects: 62
Study 31246283 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (TBP group)
Number of subjects: 62